Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination
CA 2422076 A1 · Owner: Hanna, Nabil · Inventors: Hanna, Nabil
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention concerns treatment of autoimmune diseases with the combination of an immunoregulatory antibody e.g. and anti-B7.1 or anti-B7.2 , or anti-CD40L antibody and at least one B cell antibody such as CD19, CD20, CD22, CD23, or CD37 wherein such antibodies may be administered separately or in combination, and in either, over prolonged periods of time.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 18, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 18, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 18, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.